Analysis of associations of IL4 (rs2243250), IL5 (rs2069812) and IL13 (rs1800925) gene polymorphisms with asthma severity in children
https://doi.org/10.25557/2073-7998.2026.06.36-45
Abstract
Background. Asthma in children is characterized by pronounced clinical heterogeneity, including differences in disease severity. Genetic factors associated with Th2-mediated inflammation may influence not only susceptibility to the disease but also the development of severe forms of asthma. However, the contribution of individual cytokine gene polymorphisms to asthma severity in children remains insufficiently studied.
Objective. To investigate the association of polymorphic variants of the IL4 (rs2243250), IL5 (rs2069812), and IL13 (rs1800925) genes with asthma severity in children.
Methods. A case–control study was conducted including 384 children: 160 patients with asthma of varying severity, classified according to GINA 2024 criteria, and 224 healthy children. Genotyping was performed using real-time polymerase chain reaction. Associations between genotypes and asthma severity were analyzed using ordinal logistic regression with testing of codominant, dominant, recessive, overdominant, and additive inheritance models.
Results. Among the three analyzed polymorphisms, only rs1800925 (C-1112T) of the IL13 gene showed a statistically significant association with asthma severity. The additive inheritance model was the most optimal according to the Akaike information criterion (p = 0.0027), demonstrating a dose-dependent effect: carriers of the C/C genotype had a mean asthma severity score of 0.73, C/T – 0.95, and T/T – 1.29. Polymorphisms of the IL4 and IL5 genes were not significantly associated with asthma severity.
Conclusions. The rs1800925 polymorphism of the IL13 gene is a genetic marker associated with asthma severity in children and may be used for early prediction of disease course.
Keywords
About the Authors
S. Yu. TereshchenkoRussian Federation
3g Partizana Zheleznyaka str., Krasnoyarsk, 660022
A. G. Mileyko
Russian Federation
3g Partizana Zheleznyaka str., Krasnoyarsk, 660022
N. N. Gorbacheva
Russian Federation
3g Partizana Zheleznyaka str., Krasnoyarsk, 660022
M. V. Shubina
Russian Federation
3g Partizana Zheleznyaka str., Krasnoyarsk, 660022
M. V. Smolnikova
Russian Federation
3g Partizana Zheleznyaka str., Krasnoyarsk, 660022
References
1. Pijnenburg M.W., Frey U., De Jongste J.C., Saglani S. Childhood asthma: pathogenesis and phenotypes. Eur Respir J. 2022; 59 (6):2100731 https://doi.org/10.1183/13993003.00731-2021
2. Tereshchenko S.Yu., Smolnikova M.V. Fenotipy i endotipy bronkhial’noy astmy u detey [Phenotypes and endotypes of asthma in children]. Pul’monologiya [Pulmonologiya]. 2025;35(5):623-634. (In Russ.) https://doi.org/10.18093/0869-0189-2025-35-5-623-634
3. Hernandez-Pacheco N., Pino-Yanes M., Flores C. Genomic Predictors of Asthma Phenotypes and Treatment Response. Frontiers in pediatrics. 2019 5;7:6. https://doi.org/10.3389/fped.2019.00006
4. Thomsen S.F. Exploring the origins of asthma: Lessons from twin studies. European clinical respiratory journal. 2014; 1(Suppl 1): 10.3402/ecrj.v1.25535. https://doi.org/10.3402/ecrj.v1.25535
5. Slob E.M.A., Longo C., Vijverberg S.J.H., et al. Persistence of parental-reported asthma at early ages: A longitudinal twin study. Pediatric Allergy and Immunology. 2022; 33(3):e13762. https://doi.org/https://doi.org/10.1111/pai.13762
6. Ruan Z., Shi Z., Zhang G., et al. Asthma susceptible genes in children: A meta-analysis. Medicine. 2020; 99(45):e23051. https://doi.org/10.1097/md.0000000000023051
7. Wolters A.A.B., Kersten E.T.G., Koppelman G.H. Genetics of preschool wheeze and its progression to childhood asthma. Pediatric Allergy and Immunology. 2024; 35(1):e14067. https://doi.org/https://doi.org/10.1111/pai.14067
8. Kousha A., Mahdavi Gorabi A., Forouzesh M., et al. Interleukin 4 gene polymorphism (-589C/T) and the risk of asthma: a meta-analysis and met-regression based on 55 studies. BMC immunology. 2020; 21(1):55. https://doi.org/10.1186/s12865-020-00384-7
9. Pelaia C., Paoletti G., Puggioni F., et al. Interleukin-5 in the Pathophysiology of Severe Asthma. Frontiers in physiology. 2019; 10:1514. https://doi.org/10.3389/fphys.2019.01514
10. Rojo-Tolosa S., Sánchez-Martínez J.A., Caballero-Vázquez A., et al. SingleNucleotide Polymorphisms as Biomarkers of Mepolizumab and Benralizumab Treatment Response in Severe Eosinophilic Asthma. International journal of molecular sciences. 2024; 25(15):8139. https://doi.org/10.3390/ijms25158139
11. Shen T.C., Chen G.L., Chen L.H., et al. Significant Contributions of Interleukin-13 Genotypes to Asthma Severity. In vivo (Athens, Greece). 2025; 39(5):2562-2572. https://doi.org/10.21873/invivo.14057
12. Global Initiative for Asthma (GINA). (2024). «Global Strategy for Asthma Management and Prevention.» Available from: www. ginasthma.org. Available at https://ginasthma.org/2024-report/.
13. Chang D., Hunkapiller J., Bhangale T., et al. A whole genome sequencing study of moderate to severe asthma identifies a lung function locus associated with asthma risk. Scientific reports. 2022; 12(1):5574. https://doi.org/10.1038/s41598-022-09447-8
14. Li X., Christenson S.A., Modena B., et al. Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways. J Allergy Clin Immunol. 2021; 147(3):894-909. https://doi.org/10.1016/j.jaci.2020.07.030
15. Ertoy Karagol H.I., Bakirtas A. New Perspectives in the Management of Mild to Moderate Asthma in Children. Journal of asthma and allergy. 2021; 14:293-299. https://doi.org/10.2147/jaa.s255218
16. Arima K., Umeshita-Suyama R., Sakata Y., et al. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol. 2002; 109(6):980-987. https://doi.org/10.1067/mai.2002.124656
17. Saba N., Raja G.K., Yusuf O., et al. Impacts of different cytokine and chemokine polymorphisms in Pakistani asthmatics a case control study. COPD Research and Practice. 2017; 3(1):8. https://doi.org/10.1186/s40749-017-0027-8
18. Kim H.B., Lee Y.C., Lee S.Y., et al. Gene–gene interaction between IL-13 and IL-13Rα1 is associated with total IgE in Korean children with atopic asthma. Journal of Human Genetics. 2006; 51(12):1055-1062. https://doi.org/10.1007/s10038-006-0061-x
19. Omraninava M., Eslami M.M., Aslani S., et al. Interleukin 13 gene polymorphism and susceptibility to asthma: a meta-regression and meta-analysis. European annals of allergy and clinical immunology. 2022; 54(4):150-167. https://doi.org/10.23822/EurAnnACI.1764-1489.180
20. Gaceja K.V., Ancheta Z.F.R., Buna A.C.A., et al. Association of interleukin-13 gene single nucleotide polymorphism rs1800925 with allergic asthma in Asian population: A meta-analysis. Asia Pacific allergy. 2023; 13(4):148-157. https://doi.org/10.5415/apallergy.0000000000000119
Review
For citations:
Tereshchenko S.Yu., Mileyko A.G., Gorbacheva N.N., Shubina M.V., Smolnikova M.V. Analysis of associations of IL4 (rs2243250), IL5 (rs2069812) and IL13 (rs1800925) gene polymorphisms with asthma severity in children. Medical Genetics. 2026;25(6):36-45. (In Russ.) https://doi.org/10.25557/2073-7998.2026.06.36-45
JATS XML






















